Related Experiment Video
Updated: Feb 12, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
Nitrolipids in kidney physiology and disease
Soma Jobbagy1, Roderick J Tan2
1Department of Phamacology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Nitric Oxide : Biology and Chemistry
|April 2, 2018
Summary
Nitro-oleic acid (NO2-OA) shows promise for kidney disease treatment. This endogenous compound may protect kidneys by modulating key cellular pathways involved in inflammation and oxidative stress.
Area of Science:
- Nephrology
- Biochemistry
- Pharmacology
Background:
- Kidney disease is a major health issue with limited treatment options.
- Current therapies like renin-angiotensin system blockade and renal replacement therapy have significant limitations.
- Novel pharmacological agents are urgently needed to improve patient outcomes.
Purpose of the Study:
- To investigate the potential of nitro-oleic acid (NO2-OA) as a therapeutic agent for kidney diseases.
- To explore the mechanisms by which NO2-OA exerts protective effects on kidney function.
- To evaluate NO2-OA's impact on key cellular pathways relevant to kidney health.
Main Methods:
- Investigated NO2-OA's endogenous generation and its electrophilic properties.
- Examined NO2-OA's interaction with protein thiols to alter protein function.
- Focused on the modulation of Keap1/Nrf2 and NF-κB signaling pathways.
Main Results:
- NO2-OA modifies protein thiols, impacting cellular functions.
- Identified Keap1/Nrf2 and NF-κB pathways as primary targets of NO2-OA.
- These pathways regulate crucial antioxidant, detoxifying, and inflammatory responses.
Conclusions:
- NO2-OA demonstrates potential as a novel therapeutic for kidney conditions.
- Its ability to modulate antioxidant and inflammatory pathways offers protective benefits.
- Further research into NO2-OA could lead to improved treatments for acute and chronic kidney diseases.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
01:24Chronic Kidney Disease II: Clinical Manifestations
683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
01:28Chronic Kidney Disease III: Interprofessional Care
485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
01:18Chronic Kidney Disease IV: Nursing Management
413
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
413
01:45Kidney Structure
75.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.5K
01:25Physiological Barriers
5.3K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.3K